We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+13.82%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$13B
AUM Growth
+$1.56B
Cap. Flow
+$261M
Cap. Flow %
2.02%
Top 10 Hldgs %
17.05%
Holding
1,179
New
174
Increased
377
Reduced
434
Closed
179

Top Buys

Rank Stock Value
1
COST icon
Costco
COST
+$128M
2
EA icon
Electronic Arts
EA
+$79.4M
3
BMY icon
Bristol-Myers Squibb
BMY
+$75M
4
TGT icon
Target
TGT
+$74.4M
5
AMZN icon
Amazon
AMZN
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 22.12%
2 Healthcare 14.04%
3 Consumer Discretionary 13.03%
4 Financials 12.63%
5 Industrials 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGTY
851
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$552K ﹤0.01%
26,680
-5,529
-17% -$111K
RM icon
852
Regional Management Corp
RM
$391M
$546K ﹤0.01%
15,751
+7,827
+99% +$255K
BFAM icon
853
Bright Horizons
BFAM
$4.35B
$545K ﹤0.01%
+3,177
New +$523K
BOOT icon
854
Boot Barn
BOOT
$4.58B
$545K ﹤0.01%
+8,746
New +$513K
FOSL icon
855
Fossil Group
FOSL
$260M
$538K ﹤0.01%
43,394
-2,441
-5% -$34.1K
PFGC icon
856
Performance Food Group
PFGC
$18.3B
$538K ﹤0.01%
9,345
-104,025
-92% -$5.49M
DHC
857
Diversified Healthcare Trust
DHC
$2.15B
$535K ﹤0.01%
+111,969
New +$515K
ZYNE
858
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$532K ﹤0.01%
114,439
FRST icon
859
Primis Financial Corp
FRST
$399M
$522K ﹤0.01%
+35,922
New +$494K
ALDX icon
860
Aldeyra Therapeutics
ALDX
$97.1M
$512K ﹤0.01%
43,069
-254,763
-86% -$2.93M
TNC icon
861
Tennant Co
TNC
$1.44B
$500K ﹤0.01%
6,259
+1,597
+34% +$121K
PGRE
862
DELISTED
Paramount Group
PGRE
$499K ﹤0.01%
+49,226
New +$462K
ACAD icon
863
Acadia Pharmaceuticals
ACAD
$4.51B
$486K ﹤0.01%
+18,845
New +$830K
VHI icon
864
Valhi
VHI
$389M
$484K ﹤0.01%
23,595
EOG icon
865
EOG Resources
EOG
$77.7B
$482K ﹤0.01%
6,640
-38,412
-85% -$2.45M
CFG icon
866
Citizens Financial Group
CFG
$30.1B
$481K ﹤0.01%
+10,897
New +$453K
SYRS
867
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$472K ﹤0.01%
6,311
-5,949
-49% -$618K
MIRM icon
868
Mirum Pharmaceuticals
MIRM
$6.57B
$463K ﹤0.01%
+23,339
New +$447K
AXGN icon
869
Axogen
AXGN
$2.2B
$457K ﹤0.01%
22,560
-22,384
-50% -$442K
BMRC icon
870
Bank of Marin Bancorp
BMRC
$461M
$456K ﹤0.01%
11,636
-28,303
-71% -$1.09M
MHO icon
871
M/I Homes
MHO
$3.95B
$456K ﹤0.01%
+7,724
New +$401K
JNJ icon
872
Johnson & Johnson
JNJ
$640B
$452K ﹤0.01%
2,749
-1,295
-32% -$210K
PRTK
873
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$446K ﹤0.01%
63,210
+26,220
+71% +$189K
MRCY icon
874
Mercury Systems
MRCY
$5.42B
$445K ﹤0.01%
+6,299
New +$455K
LDL
875
DELISTED
Lydall, Inc.
LDL
$443K ﹤0.01%
13,134
-107,492
-89% -$3.68M

Similar funds

Jacobs Levy Equity Management's Q1 2021 Portfolio in Review

As of Q1 2021, Jacobs Levy Equity Management held 1,179 positions worth $13B, up 14% from $11.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Jacobs Levy Equity Management's Q1 2021 filing shows 174 new, 377 increased, 434 reduced and 179 closed positions. Its largest new stake was Target: 397,775 shares worth $78.8M. The largest sale was Microsoft, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q1 2021 buy was Target: 397,775 shares worth $78.8M.
  • Jacobs Levy Equity Management added most to Costco in Q1 2021, an estimated $128M increase.
  • Jacobs Levy Equity Management's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
  • Jacobs Levy Equity Management fully exited Starbucks in Q1 2021, selling an estimated $121M.
  • Jacobs Levy Equity Management's ten largest holdings make up 17% of its $13B portfolio in Q1 2021.
  • Jacobs Levy Equity Management opened 174 new positions and closed 179 in Q1 2021.
  • Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $13B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2021, filed 17 May 2021.